Cargando…

A cross-sectional study on prevalence of chronic obstructive pulmonary disease (COPD) in India: rationale and methods

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a common preventable and treatable chronic respiratory disease, which affects 210 million people globally. Global and national guidelines exist for the management of COPD. Although evidence-based, they are inadequate to address the phenotyp...

Descripción completa

Detalles Bibliográficos
Autores principales: Rajkumar, Prabu, Pattabi, Kamaraj, Vadivoo, Selvaraj, Bhome, Arvind, Brashier, Bill, Bhattacharya, Prashanta, Mehendale, Sanjay M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5729985/
https://www.ncbi.nlm.nih.gov/pubmed/28554925
http://dx.doi.org/10.1136/bmjopen-2016-015211
_version_ 1783286278239813632
author Rajkumar, Prabu
Pattabi, Kamaraj
Vadivoo, Selvaraj
Bhome, Arvind
Brashier, Bill
Bhattacharya, Prashanta
Mehendale, Sanjay M
author_facet Rajkumar, Prabu
Pattabi, Kamaraj
Vadivoo, Selvaraj
Bhome, Arvind
Brashier, Bill
Bhattacharya, Prashanta
Mehendale, Sanjay M
author_sort Rajkumar, Prabu
collection PubMed
description BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a common preventable and treatable chronic respiratory disease, which affects 210 million people globally. Global and national guidelines exist for the management of COPD. Although evidence-based, they are inadequate to address the phenotypic and genotypic heterogeneity in India. Co-existence of other chronic respiratory diseases can adversely influence the prognosis of COPD. India has a huge burden of COPD with various risk factors and comorbid conditions. However, valid prevalence estimates employing spirometry as the diagnostic tool and data on important comorbid conditions are not available. This study protocol is designed to address this knowledge gap and eventually to build a database to undertake long-term cohort studies to describe the phenotypic and genotypic heterogeneity among COPD patients in India. OBJECTIVES: The primary objective is to estimate the prevalence of COPD among adults aged ≥25 years for each gender in India. The secondary objective is to identify the risk factors for COPD and important comorbid conditions such as asthma and post-tuberculosis sequelae. It is also proposed to validate the currently available definitions for COPD diagnosis in India. METHODS AND ANALYSIS: A cross-sectional study will be undertaken among the populations of sub-urban areas of Chennai and Shillong cities, which represent the Southern and Northeastern regions of India. We will collect data on sociodemographic variables, economic characteristics, risk factors of COPD and comorbidities. The Global Initiative for Obstructive Lung Disease (GOLD) and Global Initiative for Asthma (GINA) definitions will be used for the diagnosis of COPD and asthma. Data will be analysed for estimation of the prevalence of COPD, asthma and associated factors. ETHICS AND DISSEMINATION: This study proposal was approved by the respective institutional ethics committees of participating institutions. The results will be disseminated through publications in the peer-reviewed journals and a report will be submitted to the concerned public health authorities in India for developing appropriate research and management policies.
format Online
Article
Text
id pubmed-5729985
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-57299852017-12-19 A cross-sectional study on prevalence of chronic obstructive pulmonary disease (COPD) in India: rationale and methods Rajkumar, Prabu Pattabi, Kamaraj Vadivoo, Selvaraj Bhome, Arvind Brashier, Bill Bhattacharya, Prashanta Mehendale, Sanjay M BMJ Open Respiratory Medicine BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a common preventable and treatable chronic respiratory disease, which affects 210 million people globally. Global and national guidelines exist for the management of COPD. Although evidence-based, they are inadequate to address the phenotypic and genotypic heterogeneity in India. Co-existence of other chronic respiratory diseases can adversely influence the prognosis of COPD. India has a huge burden of COPD with various risk factors and comorbid conditions. However, valid prevalence estimates employing spirometry as the diagnostic tool and data on important comorbid conditions are not available. This study protocol is designed to address this knowledge gap and eventually to build a database to undertake long-term cohort studies to describe the phenotypic and genotypic heterogeneity among COPD patients in India. OBJECTIVES: The primary objective is to estimate the prevalence of COPD among adults aged ≥25 years for each gender in India. The secondary objective is to identify the risk factors for COPD and important comorbid conditions such as asthma and post-tuberculosis sequelae. It is also proposed to validate the currently available definitions for COPD diagnosis in India. METHODS AND ANALYSIS: A cross-sectional study will be undertaken among the populations of sub-urban areas of Chennai and Shillong cities, which represent the Southern and Northeastern regions of India. We will collect data on sociodemographic variables, economic characteristics, risk factors of COPD and comorbidities. The Global Initiative for Obstructive Lung Disease (GOLD) and Global Initiative for Asthma (GINA) definitions will be used for the diagnosis of COPD and asthma. Data will be analysed for estimation of the prevalence of COPD, asthma and associated factors. ETHICS AND DISSEMINATION: This study proposal was approved by the respective institutional ethics committees of participating institutions. The results will be disseminated through publications in the peer-reviewed journals and a report will be submitted to the concerned public health authorities in India for developing appropriate research and management policies. BMJ Publishing Group 2017-05-29 /pmc/articles/PMC5729985/ /pubmed/28554925 http://dx.doi.org/10.1136/bmjopen-2016-015211 Text en © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Respiratory Medicine
Rajkumar, Prabu
Pattabi, Kamaraj
Vadivoo, Selvaraj
Bhome, Arvind
Brashier, Bill
Bhattacharya, Prashanta
Mehendale, Sanjay M
A cross-sectional study on prevalence of chronic obstructive pulmonary disease (COPD) in India: rationale and methods
title A cross-sectional study on prevalence of chronic obstructive pulmonary disease (COPD) in India: rationale and methods
title_full A cross-sectional study on prevalence of chronic obstructive pulmonary disease (COPD) in India: rationale and methods
title_fullStr A cross-sectional study on prevalence of chronic obstructive pulmonary disease (COPD) in India: rationale and methods
title_full_unstemmed A cross-sectional study on prevalence of chronic obstructive pulmonary disease (COPD) in India: rationale and methods
title_short A cross-sectional study on prevalence of chronic obstructive pulmonary disease (COPD) in India: rationale and methods
title_sort cross-sectional study on prevalence of chronic obstructive pulmonary disease (copd) in india: rationale and methods
topic Respiratory Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5729985/
https://www.ncbi.nlm.nih.gov/pubmed/28554925
http://dx.doi.org/10.1136/bmjopen-2016-015211
work_keys_str_mv AT rajkumarprabu acrosssectionalstudyonprevalenceofchronicobstructivepulmonarydiseasecopdinindiarationaleandmethods
AT pattabikamaraj acrosssectionalstudyonprevalenceofchronicobstructivepulmonarydiseasecopdinindiarationaleandmethods
AT vadivooselvaraj acrosssectionalstudyonprevalenceofchronicobstructivepulmonarydiseasecopdinindiarationaleandmethods
AT bhomearvind acrosssectionalstudyonprevalenceofchronicobstructivepulmonarydiseasecopdinindiarationaleandmethods
AT brashierbill acrosssectionalstudyonprevalenceofchronicobstructivepulmonarydiseasecopdinindiarationaleandmethods
AT bhattacharyaprashanta acrosssectionalstudyonprevalenceofchronicobstructivepulmonarydiseasecopdinindiarationaleandmethods
AT mehendalesanjaym acrosssectionalstudyonprevalenceofchronicobstructivepulmonarydiseasecopdinindiarationaleandmethods
AT rajkumarprabu crosssectionalstudyonprevalenceofchronicobstructivepulmonarydiseasecopdinindiarationaleandmethods
AT pattabikamaraj crosssectionalstudyonprevalenceofchronicobstructivepulmonarydiseasecopdinindiarationaleandmethods
AT vadivooselvaraj crosssectionalstudyonprevalenceofchronicobstructivepulmonarydiseasecopdinindiarationaleandmethods
AT bhomearvind crosssectionalstudyonprevalenceofchronicobstructivepulmonarydiseasecopdinindiarationaleandmethods
AT brashierbill crosssectionalstudyonprevalenceofchronicobstructivepulmonarydiseasecopdinindiarationaleandmethods
AT bhattacharyaprashanta crosssectionalstudyonprevalenceofchronicobstructivepulmonarydiseasecopdinindiarationaleandmethods
AT mehendalesanjaym crosssectionalstudyonprevalenceofchronicobstructivepulmonarydiseasecopdinindiarationaleandmethods